ORGANOGENESIS INC
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ORGANOGENESIS INC, 10-Q, 2000-08-14
Next: NEW ENGLAND LIFE PENSION PROPERTIES IV, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10q AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          18,351
<SECURITIES>                                     4,015
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                        863
<CURRENT-ASSETS>                                24,950
<PP&E>                                          24,689
<DEPRECIATION>                                  11,966
<TOTAL-ASSETS>                                  38,212
<CURRENT-LIABILITIES>                            4,623
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           342
<OTHER-SE>                                      11,567
<TOTAL-LIABILITY-AND-EQUITY>                    38,212
<SALES>                                          1,331
<TOTAL-REVENUES>                                 7,502
<CGS>                                            2,434
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                12,854
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 947
<INCOME-PRETAX>                                (8,733)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,733)
<EPS-BASIC>                                      (.27)
<EPS-DILUTED>                                    (.27)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission